Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Ceritinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Ceritinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Cobimetinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Cobimetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Crizotinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Crizotinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Dacomitinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Dacomitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Dalpiciclib	CDK Inhibitor	Solid Tumour
Molecule Dalpiciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Defactinib	Focal Adhesion Kinase (FAK) Inhibitor	Solid Tumour
Molecule Defactinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Focal Adhesion Kinase (FAK) Inhibitor
Derazantinib	FGFR Inhibitor	Solid Tumour
Molecule Derazantinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Dinaciclib	CDK Inhibitor	Solid Tumour
Molecule Dinaciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Divarasib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Divarasib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Donafenib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Donafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Dovitinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Dovitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Elzovantinib	MET Inhibitor	Solid Tumour
Molecule Elzovantinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor

Ceritinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Cobimetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Crizotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Dacomitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Dalpiciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Defactinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Focal Adhesion Kinase (FAK) Inhibitor
Derazantinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Dinaciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Divarasib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Donafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Dovitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Elzovantinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor

‹ 1 2 3 4 5 6 … 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Ceritinib

Cobimetinib

Crizotinib

Dacomitinib

Dalpiciclib

Defactinib

Derazantinib

Dinaciclib

Divarasib

Donafenib

Dovitinib

Elzovantinib

Ceritinib

Cobimetinib

Crizotinib

Dacomitinib

Dalpiciclib

Defactinib

Derazantinib

Dinaciclib

Divarasib

Donafenib

Dovitinib

Elzovantinib